2m 2m 2m 2m 2m 2m 2m
MediciNova (MNOV)
NASDAQ
$1.42+$0.02 (+1.07%)
Price as of Nov 11, 2026 7:55 PM EST- $68.9MMarket Cap
- -13.04%1-Year Change
- BiotechnologyIndustry
MediciNova (MNOV)
$1.42+$0.02 (+1.07%)
MNOV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.40 | ||
Change | -$0.07 (-4.76%) | ||
Open | $1.55 | ||
High | $1.55 | ||
Low | $1.40 | ||
Previous Close | $1.47 | ||
Volume | 65,003 | ||
30-Day Average Volume | 60,509 | ||
1-Week Change | -1.41% | ||
1-Month Change | -7.89% | ||
1-Year Change | -13.04% | ||
3-Year Change | -21.35% | ||
5-Year Change | -60.45% | ||
Fundamentals | |||
Shares Outstanding | 49.2M | ||
Total Assets | $40.4M | ||
Market Cap | $68.9M | ||
Enterprise Value | $43.5M | ||
Period: QTR TTM FY | |||
Revenue | $458,439.00 | ||
Net Income | -$2.3M | ||
Free Cash Flow | -$1.9M | ||
EBIT | -$2.3M | ||
EBITDA | -$2.3M | ||
Net Working Capital | $23.0M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 95 | ||
P/B | 2 | ||
P/E | -28 | ||
PEG | N/A | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue